Literature DB >> 15855053

Differential apoptotic and redox regulatory activities of curcumin and its derivatives.

Satyendra Mishra1, Neha Kapoor, A Mubarak Ali, B V V Pardhasaradhi, A Leela Kumari, Ashok Khar, Krishna Misra.   

Abstract

We have synthesized different bioconjugates of curcumin, which were tested for their pro- and antioxidant properties. In the present study five representative derivatives of curcumin, i.e., 4,4'-di-(O-acetyl) curcumin, 4,4'-di-(O-glycinoyl) curcumin, 4,4'-di-(O-glycinoyl-di-N-piperoyl) curcumin, 4,4'-di-(O-piperoyl) curcumin, and 4,4'-(O,O-cystinoyl)-3,3'-dimethoxydiphenyl-1,6-heptadiene-3,5-dione, were used for testing their apoptotic potential on tumor cells. Dipiperoyl and diglycinoyl derivatives showed higher apoptotic activity at lower concentrations, whereas diacetyl curcumin had slightly lower apoptotic activity on tumor cells. On the other hand, diglycinoyl-dipiperoyl and cystinoyl heptadiene derivatives had lost their apoptotic potential significantly. The apoptotic activity of these derivatives correlated very well with the generation of ROS by the tumor cells, whereas GSH levels remained unaltered. Our studies also indicate downregulation of Bcl-2 and participation of caspase-3 in the apoptotic death of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855053     DOI: 10.1016/j.freeradbiomed.2005.01.022

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  12 in total

Review 1.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

2.  Dimethoxycurcumin, a structural analogue of curcumin, induces apoptosis in human renal carcinoma caki cells through the production of reactive oxygen species, the release of cytochrome C, and the activation of caspase-3.

Authors:  Jea Whan Lee; Hye Min Hong; Dong Deuk Kwon; Hyun-Ock Pae; Hee Jong Jeong
Journal:  Korean J Urol       Date:  2010-12-21

3.  Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity.

Authors:  Jyoti Upadhyay; Rajesh K Kesharwani; Krishna Misra
Journal:  Bioinformation       Date:  2009-12-06

4.  Study of interaction of human serum albumin with curcumin by NMR and docking.

Authors:  Durg Vijay Singh; Santosh Kumar Bharti; Shikha Agarwal; Raja Roy; Krishna Misra
Journal:  J Mol Model       Date:  2014-07-17       Impact factor: 1.810

5.  Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane).

Authors:  Santosh K Sandur; Haruyo Ichikawa; Manoj K Pandey; Ajaikumar B Kunnumakkara; Bokyung Sung; Gautam Sethi; Bharat B Aggarwal
Journal:  Free Radic Biol Med       Date:  2007-05-16       Impact factor: 7.376

Review 6.  Perspectives on new synthetic curcumin analogs and their potential anticancer properties.

Authors:  Alok Vyas; Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul Sarkar
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Effects of curcumin on ethanol-induced hepatocyte necrosis and apoptosis: implication of lipid peroxidation and cytochrome c.

Authors:  Asser I Ghoneim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-21       Impact factor: 3.000

8.  Medicinal management of oral submucous fibrosis in the past decade- A systematic review.

Authors:  Chandramani B More; Deepa Jatti Patil; Naman R Rao
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-19

9.  Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs.

Authors:  Kellie S Rath; Georgia A McCann; David E Cohn; Brian K Rivera; Periannan Kuppusamy; Karuppaiyah Selvendiran
Journal:  J Ovarian Res       Date:  2013-05-11       Impact factor: 4.234

10.  The antioxidant activity of some curcuminoids and chalcones.

Authors:  Münevver Sökmen; M Akram Khan
Journal:  Inflammopharmacology       Date:  2016-05-17       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.